{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:55:29Z","timestamp":1792032929307,"version":"4.4.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["CA193837"],"award-info":[{"award-number":["CA193837"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["CA092629"],"award-info":[{"award-number":["CA092629"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["CA224079"],"award-info":[{"award-number":["CA224079"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["CA155169"],"award-info":[{"award-number":["CA155169"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["1K99CA276888-01"],"award-info":[{"award-number":["1K99CA276888-01"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["CA274492"],"award-info":[{"award-number":["CA274492"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["CA008748"],"award-info":[{"award-number":["CA008748"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["DK128602-03"],"award-info":[{"award-number":["DK128602-03"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["CA008748"],"award-info":[{"award-number":["CA008748"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["CA008748"],"award-info":[{"award-number":["CA008748"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["CA008748"],"award-info":[{"award-number":["CA008748"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["CA008748"],"award-info":[{"award-number":["CA008748"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["CA224079"],"award-info":[{"award-number":["CA224079"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["CA257811"],"award-info":[{"award-number":["CA257811"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["CA274492"],"award-info":[{"award-number":["CA274492"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-19-1-0323"],"award-info":[{"award-number":["W81XWH-19-1-0323"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-21-1-0431"],"award-info":[{"award-number":["W81XWH-21-1-0431"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["20YOUN22"],"award-info":[{"award-number":["20YOUN22"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Despite the high prevalence of ERG transcription factor translocations in prostate cancer, the mechanism of tumorigenicity remains poorly understood. Using lineage tracing, we find the tumor-initiating activity of ERG resides in a subpopulation of murine basal cells that coexpress luminal genes (Basal<jats:sup>Lum<\/jats:sup>) and not in the larger population of ERG<jats:sup>+<\/jats:sup> luminal cells. Upon ERG activation, Basal<jats:sup>Lum<\/jats:sup> cells give rise to highly proliferative intermediate (IM) cells with stem-like features that coexpress basal, luminal, hillock and club marker genes, before transitioning to Krt8<jats:sup>+<\/jats:sup> luminal cells. Transcriptomic analysis of ERG<jats:sup>+<\/jats:sup> human prostate cancers confirms the presence of rare ERG<jats:sup>+<\/jats:sup> Basal<jats:sup>Lum<\/jats:sup> cells, as well as IM cells whose presence is associated with a worse prognosis. Single-cell analysis revealed a chromatin state in ERG<jats:sup>+<\/jats:sup> IM cells enriched for STAT3 transcription factor binding sites and elevated expression of the KMT2A\/MLL1 and DOT1L, all three of which are essential for ERG-driven tumorigenicity in vivo. In addition to providing translational opportunities, this work illustrates how single-cell approaches combined with lineage tracing can identify cancer vulnerabilities not evident from bulk analysis.<\/jats:p>","DOI":"10.1038\/s41588-025-02289-w","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T09:04:03Z","timestamp":1756199043000},"page":"2177-2191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["ERG-driven prostate cancer initiation is cell-context dependent and requires KMT2A and DOT1L"],"prefix":"10.1038","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3422-4964","authenticated-orcid":false,"given":"Weiran","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Ladewig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7526-2140","authenticated-orcid":false,"given":"Matthew","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazifa","family":"Salsabeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Sun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Gopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanzhi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6355-1457","authenticated-orcid":false,"given":"Eric","family":"Rosiek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"de Stanchina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0171-3884","authenticated-orcid":false,"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5165-3544","authenticated-orcid":false,"given":"Brett S.","family":"Carver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4571-5910","authenticated-orcid":false,"given":"Christina S.","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4955-6475","authenticated-orcid":false,"given":"Charles L.","family":"Sawyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"2289_CR1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ng.370","volume":"41","author":"BS Carver","year":"2009","unstructured":"Carver, B. S. et al. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat. Genet. 41, 619\u2013624 (2009).","journal-title":"Nat. Genet."},{"key":"2289_CR2","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1593\/neo.06427","volume":"8","author":"N Cerveira","year":"2006","unstructured":"Cerveira, N. et al. TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions. Neoplasia 8, 826\u2013832 (2006).","journal-title":"Neoplasia"},{"key":"2289_CR3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm.3216","volume":"19","author":"Y Chen","year":"2013","unstructured":"Chen, Y. et al. ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss. Nat. Med. 19, 1023\u20131029 (2013).","journal-title":"Nat. Med."},{"key":"2289_CR4","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.ccell.2018.10.016","volume":"34","author":"C Gerhauser","year":"2018","unstructured":"Gerhauser, C. et al. Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories. Cancer Cell 34, 996\u20131011 e8 (2018).","journal-title":"Cancer Cell"},{"key":"2289_CR5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/ng.371","volume":"41","author":"JC King","year":"2009","unstructured":"King, J. C. et al. Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis. Nat. Genet. 41, 524\u2013526 (2009).","journal-title":"Nat. Genet."},{"key":"2289_CR6","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1158\/1078-0432.CCR-07-5194","volume":"14","author":"JM Mosquera","year":"2008","unstructured":"Mosquera, J. M. et al. Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications. Clin. Cancer Res. 14, 3380\u20133385 (2008).","journal-title":"Clin. Cancer Res."},{"key":"2289_CR7","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/01.pas.0000213424.38503.aa","volume":"31","author":"S Perner","year":"2007","unstructured":"Perner, S. et al. TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am. J. Surg. Pathol. 31, 882\u2013888 (2007).","journal-title":"Am. J. Surg. Pathol."},{"key":"2289_CR8","doi-asserted-by":"crossref","first-page":"e2018976118","DOI":"10.1073\/pnas.2018976118","volume":"118","author":"E Shrestha","year":"2021","unstructured":"Shrestha, E. et al. Oncogenic gene fusions in nonneoplastic precursors as evidence that bacterial infection can initiate prostate cancer. Proc. Natl Acad. Sci. USA 118, e2018976118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2289_CR9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor, B. S. et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11\u201322 (2010).","journal-title":"Cancer Cell"},{"key":"2289_CR10","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nature22820","volume":"546","author":"R Bose","year":"2017","unstructured":"Bose, R. et al. ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis. Nature 546, 671\u2013675 (2017).","journal-title":"Nature"},{"key":"2289_CR11","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ccr.2011.04.010","volume":"19","author":"JC Brenner","year":"2011","unstructured":"Brenner, J. C. et al. Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer. Cancer Cell 19, 664\u2013678 (2011).","journal-title":"Cancer Cell"},{"key":"2289_CR12","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1172\/JCI66666","volume":"123","author":"C Cai","year":"2013","unstructured":"Cai, C. et al. ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer. J. Clin. Invest. 123, 1109\u20131122 (2013).","journal-title":"J. Clin. Invest."},{"key":"2289_CR13","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1158\/0008-5472.CAN-10-0244","volume":"70","author":"S Gupta","year":"2010","unstructured":"Gupta, S. et al. FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res. 70, 6735\u20136745 (2010).","journal-title":"Cancer Res."},{"key":"2289_CR14","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1101\/gad.17546311","volume":"25","author":"PC Hollenhorst","year":"2011","unstructured":"Hollenhorst, P. C. et al. Oncogenic ETS proteins mimic activated RAS\/MAPK signaling in prostate cells. Genes Dev. 25, 2147\u20132157 (2011).","journal-title":"Genes Dev."},{"key":"2289_CR15","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.3892\/or.2016.4747","volume":"35","author":"TD Kim","year":"2016","unstructured":"Kim, T. D., Shin, S. & Janknecht, R. ETS transcription factor ERG cooperates with histone demethylase KDM4A. Oncol. Rep. 35, 3679\u20133688 (2016).","journal-title":"Oncol. Rep."},{"key":"2289_CR16","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/ng.3930","volume":"49","author":"KJ Kron","year":"2017","unstructured":"Kron, K. J. et al. TMPRSS2-ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer. Nat. Genet. 49, 1336\u20131345 (2017).","journal-title":"Nat. Genet."},{"key":"2289_CR17","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.1172\/JCI137967","volume":"130","author":"F Li","year":"2020","unstructured":"Li, F. et al. ERG orchestrates chromatin interactions to drive prostate cell fate reprogramming. J. Clin. Invest. 130, 5924\u20135941 (2020).","journal-title":"J. Clin. Invest."},{"key":"2289_CR18","volume":"14","author":"SY Liao","year":"2023","unstructured":"Liao, S. Y. et al. SND1 binds to ERG and promotes tumor growth in genetic mouse models of prostate cancer. Nat. Commun. 14, 7435 (2023).","journal-title":"Nat. Commun."},{"key":"2289_CR19","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1158\/0008-5472.CAN-15-1911","volume":"76","author":"DE Linn","year":"2016","unstructured":"Linn, D. E., Penney, K. L., Bronson, R. T., Mucci, L. A. & Li, Z. Deletion of interstitial genes between TMPRSS2 and ERG promotes prostate cancer progression. Cancer Res. 76, 1869\u20131881 (2016).","journal-title":"Cancer Res."},{"key":"2289_CR20","doi-asserted-by":"crossref","first-page":"9420","DOI":"10.1074\/jbc.M117.783787","volume":"292","author":"CY Liu","year":"2017","unstructured":"Liu, C. Y., Yu, T., Huang, Y., Cui, L. & Hong, W. ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer. J. Biol. Chem. 292, 9420\u20139430 (2017).","journal-title":"J. Biol. Chem."},{"key":"2289_CR21","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1158\/1535-7163.MCT-18-1386","volume":"18","author":"N Mao","year":"2019","unstructured":"Mao, N. et al. Aberrant expression of ERG promotes resistance to combined PI3K and AR pathway inhibition through maintenance of AR target genes. Mol. Cancer Ther. 18, 1577\u20131586 (2019).","journal-title":"Mol. Cancer Ther."},{"key":"2289_CR22","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1038\/onc.2014.308","volume":"34","author":"Z Mounir","year":"2015","unstructured":"Mounir, Z. et al. TMPRSS2:ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferation. Oncogene 34, 3815\u20133825 (2015).","journal-title":"Oncogene"},{"key":"2289_CR23","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ccell.2015.05.005","volume":"27","author":"LT Nguyen","year":"2015","unstructured":"Nguyen, L. T. et al. ERG activates the YAP1 transcriptional program and induces the development of age-related prostate tumors. Cancer Cell 27, 797\u2013808 (2015).","journal-title":"Cancer Cell"},{"key":"2289_CR24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.molcel.2018.06.040","volume":"71","author":"GJ Sandoval","year":"2018","unstructured":"Sandoval, G. J. et al. Binding of TMPRSS2-ERG to BAF chromatin remodeling complexes mediates prostate oncogenesis. Mol. Cell 71, 554\u2013566 (2018).","journal-title":"Mol. Cell"},{"key":"2289_CR25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1593\/neo.07822","volume":"10","author":"SA Tomlins","year":"2008","unstructured":"Tomlins, S. A. et al. Role of the TMPRSS2-ERG gene fusion in prostate cancer. Neoplasia 10, 177\u2013188 (2008).","journal-title":"Neoplasia"},{"key":"2289_CR26","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1158\/0008-5472.CAN-10-2210","volume":"71","author":"J Wang","year":"2011","unstructured":"Wang, J. et al. Activation of NF-\u03baB by TMPRSS2\/ERG fusion isoforms through Toll-like receptor-4. Cancer Res. 71, 1325\u20131333 (2011).","journal-title":"Cancer Res."},{"key":"2289_CR27","doi-asserted-by":"crossref","first-page":"8584","DOI":"10.1073\/pnas.1922159117","volume":"117","author":"EV Wasmuth","year":"2020","unstructured":"Wasmuth, E. V. et al. Modulation of androgen receptor DNA binding activity through direct interaction with the ETS transcription factor ERG. Proc. Natl Acad. Sci. USA 117, 8584\u20138592 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2289_CR28","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1158\/0008-5472.CAN-13-0882","volume":"73","author":"L Wu","year":"2013","unstructured":"Wu, L. et al. ERG is a critical regulator of Wnt\/LEF1 signaling in prostate cancer. Cancer Res. 73, 6068\u20136079 (2013).","journal-title":"Cancer Res."},{"key":"2289_CR29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ccr.2010.03.018","volume":"17","author":"J Yu","year":"2010","unstructured":"Yu, J. et al. An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell 17, 443\u2013454 (2010).","journal-title":"Cancer Cell"},{"key":"2289_CR30","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","volume":"163","author":"The Cancer Genome Atlas Research Network.","year":"2015","unstructured":"The Cancer Genome Atlas Research Network. The molecular taxonomy of primary prostate cancer. Cell 163, 1011\u20131025 (2015).","journal-title":"Cell"},{"key":"2289_CR31","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1126\/science.1189992","volume":"329","author":"AS Goldstein","year":"2010","unstructured":"Goldstein, A. S., Huang, J., Guo, C., Garraway, I. P. & Witte, O. N. Identification of a cell of origin for human prostate cancer. Science 329, 568\u2013571 (2010).","journal-title":"Science"},{"key":"2289_CR32","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0913873107","volume":"107","author":"DA Lawson","year":"2010","unstructured":"Lawson, D. A. et al. Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proc. Natl Acad. Sci. USA 107, 2610\u20132615 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2289_CR33","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.ajpath.2012.11.025","volume":"182","author":"TL Lu","year":"2013","unstructured":"Lu, T. L. et al. Conditionally ablated Pten in prostate basal cells promotes basal-to-luminal differentiation and causes invasive prostate cancer in mice. Am. J. Pathol. 182, 975\u2013991 (2013).","journal-title":"Am. J. Pathol."},{"key":"2289_CR34","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1073\/pnas.1603645113","volume":"113","author":"JW Park","year":"2016","unstructured":"Park, J. W. et al. Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay. Proc. Natl Acad. Sci. USA 113, 4482\u20134487 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2289_CR35","doi-asserted-by":"crossref","first-page":"20111","DOI":"10.1073\/pnas.1320565110","volume":"110","author":"T Stoyanova","year":"2013","unstructured":"Stoyanova, T. et al. Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells. Proc. Natl Acad. Sci. USA 110, 20111\u201320116 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2289_CR36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ccr.2012.01.005","volume":"21","author":"N Choi","year":"2012","unstructured":"Choi, N., Zhang, B., Zhang, L., Ittmann, M. & Xin, L. Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation. Cancer Cell 21, 253\u2013265 (2012).","journal-title":"Cancer Cell"},{"key":"2289_CR37","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature08361","volume":"461","author":"X Wang","year":"2009","unstructured":"Wang, X. et al. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 461, 495\u2013500 (2009).","journal-title":"Nature"},{"key":"2289_CR38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/ncb2697","volume":"15","author":"ZA Wang","year":"2013","unstructured":"Wang, Z. A. et al. Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity. Nat. Cell Biol. 15, 274\u2013283 (2013).","journal-title":"Nat. Cell Biol."},{"key":"2289_CR39","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.celrep.2014.08.002","volume":"8","author":"ZA Wang","year":"2014","unstructured":"Wang, Z. A., Toivanen, R., Bergren, S. K., Chambon, P. & Shen, M. M. Luminal cells are favored as the cell of origin for prostate cancer. Cell Rep. 8, 1339\u20131346 (2014).","journal-title":"Cell Rep."},{"key":"2289_CR40","volume":"7","author":"YA Yoo","year":"2016","unstructured":"Yoo, Y. A. et al. Bmi1 marks distinct castration-resistant luminal progenitor cells competent for prostate regeneration and tumour initiation. Nat. Commun. 7, 12943 (2016).","journal-title":"Nat. Commun."},{"key":"2289_CR41","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1182\/blood-2017-12-818948","volume":"131","author":"EM Stein","year":"2018","unstructured":"Stein, E. M. et al. The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia. Blood 131, 2661\u20132669 (2018).","journal-title":"Blood"},{"key":"2289_CR42","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1158\/1078-0432.CCR-24-2920","volume":"31","author":"AM Tsimberidou","year":"2025","unstructured":"Tsimberidou, A. M. et al. Phase 1 trial of TTI-101, a first-in-class oral inhibitor of STAT3 in patients with advanced solid tumors. Clin. Cancer Res. 31, 965\u2013974 (2025).","journal-title":"Clin. Cancer Res."},{"key":"2289_CR43","doi-asserted-by":"crossref","first-page":"e2110344118","DOI":"10.1073\/pnas.2110344118","volume":"118","author":"W Feng","year":"2021","unstructured":"Feng, W. et al. Rapid interrogation of cancer cell of origin through CRISPR editing. Proc. Natl Acad. Sci. USA 118, e2110344118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2289_CR44","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.molcel.2009.10.020","volume":"36","author":"JD Norris","year":"2009","unstructured":"Norris, J. D. et al. The homeodomain protein HOXB13 regulates the cellular response to androgens. Mol. Cell 36, 405\u2013416 (2009).","journal-title":"Mol. Cell"},{"key":"2289_CR45","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.molcel.2007.05.041","volume":"27","author":"Q Wang","year":"2007","unstructured":"Wang, Q. et al. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol. Cell 27, 380\u2013392 (2007).","journal-title":"Mol. Cell"},{"key":"2289_CR46","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.2353\/ajpath.2010.090665","volume":"176","author":"YW Chen","year":"2010","unstructured":"Chen, Y. W. et al. TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells. Am. J. Pathol. 176, 2986\u20132996 (2010).","journal-title":"Am. J. Pathol."},{"key":"2289_CR47","doi-asserted-by":"crossref","first-page":"e0161084","DOI":"10.1371\/journal.pone.0161084","volume":"11","author":"D Gao","year":"2016","unstructured":"Gao, D. et al. A Tmprss2-CreERT2 knock-in mouse model for cancer genetic studies on prostate and colon. PLoS ONE 11, e0161084 (2016).","journal-title":"PLoS ONE"},{"key":"2289_CR48","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.aay0267","volume":"368","author":"WR Karthaus","year":"2020","unstructured":"Karthaus, W. R. et al. Regenerative potential of prostate luminal cells revealed by single-cell analysis. Science 368, 497\u2013505 (2020).","journal-title":"Science"},{"key":"2289_CR49","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1038\/s41588-024-01979-1","volume":"56","author":"W Guo","year":"2024","unstructured":"Guo, W. et al. JAK\/STAT signaling maintains an intermediate cell population during prostate basal cell fate determination. Nat. Genet. 56, 2776\u20132789 (2024).","journal-title":"Nat. Genet."},{"key":"2289_CR50","doi-asserted-by":"publisher","unstructured":"Luo, F. et al. A luminal intermediate cell state maintains long-term prostate homeostasis and contributes to tumorigenesis. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.02.24.529762 (2023).","DOI":"10.1101\/2023.02.24.529762"},{"key":"2289_CR51","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-36325-2","volume":"14","author":"T Hirz","year":"2023","unstructured":"Hirz, T. et al. Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses. Nat. Commun. 14, 663 (2023).","journal-title":"Nat. Commun."},{"key":"2289_CR52","volume":"13","author":"H Song","year":"2022","unstructured":"Song, H. et al. Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states. Nat. Commun. 13, 141 (2022).","journal-title":"Nat. Commun."},{"key":"2289_CR53","doi-asserted-by":"crossref","first-page":"e41668","DOI":"10.1371\/journal.pone.0041668","volume":"7","author":"OM Casey","year":"2012","unstructured":"Casey, O. M. et al. TMPRSS2-driven ERG expression in vivo increases self-renewal and maintains expression in a castration resistant subpopulation. PLoS ONE 7, e41668 (2012).","journal-title":"PLoS ONE"},{"key":"2289_CR54","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms2627","volume":"4","author":"ES Polson","year":"2013","unstructured":"Polson, E. S. et al. Monoallelic expression of TMPRSS2\/ERG in prostate cancer stem cells. Nat. Commun. 4, 1623 (2013).","journal-title":"Nat. Commun."},{"key":"2289_CR55","first-page":"4180","volume":"59","author":"B Lin","year":"1999","unstructured":"Lin, B. et al. Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. Cancer Res. 59, 4180\u20134184 (1999).","journal-title":"Cancer Res."},{"key":"2289_CR56","doi-asserted-by":"crossref","first-page":"E3506","DOI":"10.1073\/pnas.1303558110","volume":"110","author":"A Aytes","year":"2013","unstructured":"Aytes, A. et al. ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer. Proc. Natl Acad. Sci. USA 110, E3506\u2013E3515 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2289_CR57","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1158\/2159-8290.CD-16-1174","volume":"7","author":"M Zou","year":"2017","unstructured":"Zou, M. et al. Transdifferentiation as a mechanism of treatment resistance in a mouse model of castration-resistant prostate cancer. Cancer Discov. 7, 736\u2013749 (2017).","journal-title":"Cancer Discov."},{"key":"2289_CR58","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature10573","volume":"479","author":"A Van Keymeulen","year":"2011","unstructured":"Van Keymeulen, A. et al. Distinct stem cells contribute to mammary gland development and maintenance. Nature 479, 189\u2013193 (2011).","journal-title":"Nature"},{"key":"2289_CR59","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s11248-012-9598-y","volume":"21","author":"L Zhang","year":"2012","unstructured":"Zhang, L. et al. Targeting CreERT2 expression to keratin 8-expressing murine simple epithelia using bacterial artificial chromosome transgenesis. Transgenic Res. 21, 1117\u20131123 (2012).","journal-title":"Transgenic Res."},{"key":"2289_CR60","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/002215540104900214","volume":"49","author":"DL Hudson","year":"2001","unstructured":"Hudson, D. L. et al. Epithelial cell differentiation pathways in the human prostate: identification of intermediate phenotypes by keratin expression. J. Histochem. Cytochem. 49, 271\u2013278 (2001).","journal-title":"J. Histochem. Cytochem."},{"key":"2289_CR61","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s004410050633","volume":"285","author":"DM Peehl","year":"1996","unstructured":"Peehl, D. M., Sellers, R. G. & McNeal, J. E. Keratin 19 in the adult human prostate: tissue and cell culture studies. Cell Tissue Res. 285, 171\u2013176 (1996).","journal-title":"Cell Tissue Res."},{"key":"2289_CR62","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/(SICI)1097-0045(19981101)37:3<149::AID-PROS4>3.0.CO;2-E","volume":"37","author":"EJ Robinson","year":"1998","unstructured":"Robinson, E. J., Neal, D. E. & Collins, A. T. Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium. Prostate 37, 149\u2013160 (1998).","journal-title":"Prostate"},{"key":"2289_CR63","doi-asserted-by":"crossref","first-page":"R273","DOI":"10.1677\/ERC-10-0145","volume":"17","author":"RA Taylor","year":"2010","unstructured":"Taylor, R. A., Toivanen, R. & Risbridger, G. P. Stem cells in prostate cancer: treating the root of the problem. Endocr. Relat. Cancer 17, R273\u2013R285 (2010).","journal-title":"Endocr. Relat. Cancer"},{"key":"2289_CR64","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/labinvest.3780133","volume":"80","author":"G van Leenders","year":"2000","unstructured":"van Leenders, G., Dijkman, H., Hulsbergen-van de Kaa, C., Ruiter, D. & Schalken, J. Demonstration of intermediate cells during human prostate epithelial differentiation in situ and in vitro using triple-staining confocal scanning microscopy. Lab. Invest. 80, 1251\u20131258 (2000).","journal-title":"Lab. Invest."},{"key":"2289_CR65","first-page":"6182","volume":"52","author":"AP Verhagen","year":"1992","unstructured":"Verhagen, A. P. et al. Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res. 52, 6182\u20136187 (1992).","journal-title":"Cancer Res."},{"key":"2289_CR66","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1432-0436.2001.680414.x","volume":"68","author":"Y Wang","year":"2001","unstructured":"Wang, Y., Hayward, S., Cao, M., Thayer, K. & Cunha, G. Cell differentiation lineage in the prostate. Differentiation 68, 270\u2013279 (2001).","journal-title":"Differentiation"},{"key":"2289_CR67","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/(SICI)1097-0045(19980301)34:4<292::AID-PROS7>3.0.CO;2-J","volume":"34","author":"Y Xue","year":"1998","unstructured":"Xue, Y., Smedts, F., Debruyne, F. M., de la Rosette, J. J. & Schalken, J. A. Identification of intermediate cell types by keratin expression in the developing human prostate. Prostate 34, 292\u2013301 (1998).","journal-title":"Prostate"},{"key":"2289_CR68","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nature03918","volume":"436","author":"Z Chen","year":"2005","unstructured":"Chen, Z. et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436, 725\u2013730 (2005).","journal-title":"Nature"},{"key":"2289_CR69","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s43018-023-00594-z","volume":"4","author":"D Brina","year":"2023","unstructured":"Brina, D. et al. The Akt\/mTOR and MNK\/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells. Nat. Cancer 4, 1102\u20131121 (2023).","journal-title":"Nat. Cancer"},{"key":"2289_CR70","doi-asserted-by":"crossref","first-page":"e59465","DOI":"10.7554\/eLife.59465","volume":"9","author":"L Crowley","year":"2020","unstructured":"Crowley, L. et al. A single-cell atlas of the mouse and human prostate reveals heterogeneity and conservation of epithelial progenitors. eLife 9, e59465 (2020).","journal-title":"eLife"},{"key":"2289_CR71","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41588-020-0642-1","volume":"52","author":"W Guo","year":"2020","unstructured":"Guo, W. et al. Single-cell transcriptomics identifies a distinct luminal progenitor cell type in distal prostate invagination tips. Nat. Genet. 52, 908\u2013918 (2020).","journal-title":"Nat. Genet."},{"key":"2289_CR72","doi-asserted-by":"crossref","first-page":"e79076","DOI":"10.7554\/eLife.79076","volume":"11","author":"AA Germanos","year":"2022","unstructured":"Germanos, A. A. et al. Defining cellular population dynamics at single-cell resolution during prostate cancer progression. eLife 11, e79076 (2022).","journal-title":"eLife"},{"key":"2289_CR73","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41586-024-07377-1","volume":"629","author":"B Lin","year":"2024","unstructured":"Lin, B. et al. Airway hillocks are injury-resistant reservoirs of unique plastic stem cells. Nature 629, 869\u2013877 (2024).","journal-title":"Nature"},{"key":"2289_CR74","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1016\/j.celrep.2018.11.086","volume":"25","author":"GH Henry","year":"2018","unstructured":"Henry, G. H. et al. A cellular anatomy of the normal adult human prostate and prostatic urethra. Cell Rep. 25, 3530\u20133542 (2018).","journal-title":"Cell Rep."},{"key":"2289_CR75","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen, Y. et al. Club cells employ regeneration mechanisms during lung tumorigenesis. Nat. Commun. 13, 4557 (2022).","journal-title":"Nat. Commun."},{"key":"2289_CR76","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/path.6149","volume":"261","author":"FW Huang","year":"2023","unstructured":"Huang, F. W. et al. Club-like cells in proliferative inflammatory atrophy of the prostate. J. Pathol. 261, 85\u201395 (2023).","journal-title":"J. Pathol."},{"key":"2289_CR77","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41587-019-0068-4","volume":"37","author":"M Setty","year":"2019","unstructured":"Setty, M. et al. Characterization of cell fate probabilities in single-cell data with Palantir. Nat. Biotechnol. 37, 451\u2013460 (2019).","journal-title":"Nat. Biotechnol."},{"key":"2289_CR78","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0002-9440(10)64814-6","volume":"157","author":"S Signoretti","year":"2000","unstructured":"Signoretti, S. et al. p63 is a prostate basal cell marker and is required for prostate development. Am. J. Pathol. 157, 1769\u20131775 (2000).","journal-title":"Am. J. Pathol."},{"key":"2289_CR79","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41586-019-1318-9","volume":"571","author":"EJ Adams","year":"2019","unstructured":"Adams, E. J. et al. FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes. Nature 571, 408\u2013412 (2019).","journal-title":"Nature"},{"key":"2289_CR80","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ncb1530","volume":"9","author":"ML Asselin-Labat","year":"2007","unstructured":"Asselin-Labat, M. L. et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat. Cell Biol. 9, 201\u2013209 (2007).","journal-title":"Nat. Cell Biol."},{"key":"2289_CR81","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cell.2006.09.048","volume":"127","author":"H Kouros-Mehr","year":"2006","unstructured":"Kouros-Mehr, H., Slorach, E. M., Sternlicht, M. D. & Werb, Z. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127, 1041\u20131055 (2006).","journal-title":"Cell"},{"key":"2289_CR82","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41586-019-1347-4","volume":"571","author":"A Parolia","year":"2019","unstructured":"Parolia, A. et al. Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer. Nature 571, 413\u2013418 (2019).","journal-title":"Nature"},{"key":"2289_CR83","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/ng.3419","volume":"47","author":"MM Pomerantz","year":"2015","unstructured":"Pomerantz, M. M. et al. The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis. Nat. Genet. 47, 1346\u20131351 (2015).","journal-title":"Nat. Genet."},{"key":"2289_CR84","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ccell.2019.11.001","volume":"36","author":"AV Krivtsov","year":"2019","unstructured":"Krivtsov, A. V. et al. A Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia. Cancer Cell 36, 660\u2013673 (2019).","journal-title":"Cancer Cell"},{"key":"2289_CR85","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41586-023-05812-3","volume":"615","author":"GC Issa","year":"2023","unstructured":"Issa, G. C. et al. The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia. Nature 615, 920\u2013924 (2023).","journal-title":"Nature"},{"key":"2289_CR86","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1200\/JCO.24.00826","volume":"43","author":"GC Issa","year":"2025","unstructured":"Issa, G. C. et al. Menin inhibition with revumenib for KMT2A-rearranged relapsed or refractory acute leukemia (AUGMENT-101). J. Clin. Oncol. 43, 75\u201384 (2025).","journal-title":"J. Clin. Oncol."},{"key":"2289_CR87","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/15592294.2019.1699991","volume":"15","author":"F Sarno","year":"2020","unstructured":"Sarno, F., Nebbioso, A. & Altucci, L. DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatment. Epigenetics 15, 439\u2013453 (2020).","journal-title":"Epigenetics"},{"key":"2289_CR88","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18013-7","volume":"11","author":"R Vatapalli","year":"2020","unstructured":"Vatapalli, R. et al. Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. Nat. Commun. 11, 4153 (2020).","journal-title":"Nat. Commun."},{"key":"2289_CR89","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood-2012-11-465120","volume":"121","author":"AJ Deshpande","year":"2013","unstructured":"Deshpande, A. J. et al. Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l. Blood 121, 2533\u20132541 (2013).","journal-title":"Blood"},{"key":"2289_CR90","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nm.3830","volume":"21","author":"R Malik","year":"2015","unstructured":"Malik, R. et al. Targeting the MLL complex in castration-resistant prostate cancer. Nat. Med. 21, 344\u2013352 (2015).","journal-title":"Nat. Med."},{"key":"2289_CR91","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1158\/2159-8290.CD-21-0646","volume":"12","author":"ML Hemming","year":"2022","unstructured":"Hemming, M. L. et al. MOZ and Menin-MLL complexes are complementary regulators of chromatin association and transcriptional output in gastrointestinal stromal tumor. Cancer Discov. 12, 1804\u20131823 (2022).","journal-title":"Cancer Discov."},{"key":"2289_CR92","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nature09409","volume":"467","author":"P Chi","year":"2010","unstructured":"Chi, P. et al. ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours. Nature 467, 849\u2013853 (2010).","journal-title":"Nature"},{"key":"2289_CR93","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","volume":"96","author":"MW Deininger","year":"2000","unstructured":"Deininger, M. W., Goldman, J. M. & Melo, J. V. The molecular biology of chronic myeloid leukemia. Blood 96, 3343\u20133356 (2000).","journal-title":"Blood"},{"key":"2289_CR94","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41568-019-0230-9","volume":"20","author":"D Vetrie","year":"2020","unstructured":"Vetrie, D., Helgason, G. V. & Copland, M. The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML. Nat. Rev. Cancer 20, 158\u2013173 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"2289_CR95","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0925-4773(00)00551-7","volume":"101","author":"X Wu","year":"2001","unstructured":"Wu, X. et al. Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mech. Dev. 101, 61\u201369 (2001).","journal-title":"Mech. Dev."},{"key":"2289_CR96","doi-asserted-by":"crossref","first-page":"E59","DOI":"10.1371\/journal.pbio.0000059","volume":"1","author":"LC Trotman","year":"2003","unstructured":"Trotman, L. C. et al. Pten dose dictates cancer progression in the prostate. PLoS Biol. 1, E59 (2003).","journal-title":"PLoS Biol."},{"key":"2289_CR97","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nn.2467","volume":"13","author":"L Madisen","year":"2010","unstructured":"Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133\u2013140 (2010).","journal-title":"Nat. Neurosci."},{"key":"2289_CR98","doi-asserted-by":"crossref","first-page":"8551","DOI":"10.1073\/pnas.96.15.8551","volume":"96","author":"V Vasioukhin","year":"1999","unstructured":"Vasioukhin, V., Degenstein, L., Wise, B. & Fuchs, E. The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin. Proc. Natl Acad. Sci. USA 96, 8551\u20138556 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2289_CR99","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nprot.2016.006","volume":"11","author":"J Drost","year":"2016","unstructured":"Drost, J. et al. Organoid culture systems for prostate epithelial and cancer tissue. Nat. Protoc. 11, 347\u2013358 (2016).","journal-title":"Nat. Protoc."},{"key":"2289_CR100","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cell.2014.08.017","volume":"159","author":"WR Karthaus","year":"2014","unstructured":"Karthaus, W. R. et al. Identification of multipotent luminal progenitor cells in human prostate organoid cultures. Cell 159, 163\u2013175 (2014).","journal-title":"Cell"},{"key":"2289_CR101","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1073\/pnas.0609684104","volume":"104","author":"DA Lawson","year":"2007","unstructured":"Lawson, D. A., Xin, L., Lukacs, R. U., Cheng, D. & Witte, O. N. Isolation and functional characterization of murine prostate stem cells. Proc. Natl Acad. Sci. USA 104, 181\u2013186 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2289_CR102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pros.20244","volume":"65","author":"CC Leow","year":"2005","unstructured":"Leow, C. C., Wang, X. D. & Gao, W. Q. Novel method of generating prostate-specific Cre-LoxP gene switching via intraductal delivery of adenovirus. Prostate 65, 1\u20139 (2005).","journal-title":"Prostate"},{"key":"2289_CR103","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/nprot.2009.95","volume":"4","author":"M DuPage","year":"2009","unstructured":"DuPage, M., Dooley, A. L. & Jacks, T. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat. Protoc. 4, 1064\u20131072 (2009).","journal-title":"Nat. Protoc."},{"key":"2289_CR104","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1158\/0008-5472.CAN-21-1254","volume":"81","author":"S Park","year":"2021","unstructured":"Park, S. et al. Novel mouse models of bladder cancer identify a prognostic signature associated with risk of disease progression. Cancer Res. 81, 5161\u20135175 (2021).","journal-title":"Cancer Res."},{"key":"2289_CR105","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.stemcr.2014.04.004","volume":"2","author":"L Tao","year":"2014","unstructured":"Tao, L., van Bragt, M. P., Laudadio, E. & Li, Z. Lineage tracing of mammary epithelial cells using cell-type-specific cre-expressing adenoviruses. Stem Cell Rep. 2, 770\u2013779 (2014).","journal-title":"Stem Cell Rep."},{"key":"2289_CR106","volume":"7","author":"JL Schmid-Burgk","year":"2016","unstructured":"Schmid-Burgk, J. L., Honing, K., Ebert, T. S. & Hornung, V. CRISPaint allows modular base-specific gene tagging using a ligase-4-dependent mechanism. Nat. Commun. 7, 12338 (2016).","journal-title":"Nat. Commun."},{"key":"2289_CR107","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41556-020-0472-5","volume":"22","author":"B Artegiani","year":"2020","unstructured":"Artegiani, B. et al. Fast and efficient generation of knock-in human organoids using homology-independent CRISPR-Cas9 precision genome editing. Nat. Cell Biol. 22, 321\u2013331 (2020).","journal-title":"Nat. Cell Biol."},{"key":"2289_CR108","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783\u2013784 (2014).","journal-title":"Nat. Methods"},{"key":"2289_CR109","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013).","journal-title":"BMC Bioinformatics"},{"key":"2289_CR110","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res."},{"key":"2289_CR111","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie, Z. et al. Gene set knowledge discovery with Enrichr. Curr. Protoc. 1, e90 (2021).","journal-title":"Curr. Protoc."},{"key":"2289_CR112","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 (2021).","journal-title":"Cell"},{"key":"2289_CR113","doi-asserted-by":"publisher","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/060012 (2021).","DOI":"10.1101\/060012"},{"key":"2289_CR114","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/s41587-019-0332-7","volume":"37","author":"JM Granja","year":"2019","unstructured":"Granja, J. M. et al. Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia. Nat. Biotechnol. 37, 1458\u20131465 (2019).","journal-title":"Nat. Biotechnol."},{"key":"2289_CR115","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"2289_CR116","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41586-020-2528-x","volume":"583","author":"J Vierstra","year":"2020","unstructured":"Vierstra, J. et al. Global reference mapping of human transcription factor footprints. Nature 583, 729\u2013736 (2020).","journal-title":"Nature"},{"key":"2289_CR117","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nmeth.4401","volume":"14","author":"AN Schep","year":"2017","unstructured":"Schep, A. N., Wu, B., Buenrostro, J. D. & Greenleaf, W. J. chromVAR: inferring transcription-factor-associated accessibility from single-cell epigenomic data. Nat. Methods 14, 975\u2013978 (2017).","journal-title":"Nat. Methods"},{"key":"2289_CR118","doi-asserted-by":"publisher","unstructured":"Feng, W. et al. ERG-driven prostate cancer initiation is cell context dependent and requires KMT2A and DOT1L. Zenodo https:\/\/doi.org\/10.5281\/zenodo.15802144 (2025).","DOI":"10.5281\/zenodo.15802144"}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02289-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02289-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02289-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:01:24Z","timestamp":1757599284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02289-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":118,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["2289"],"URL":"https:\/\/doi.org\/10.1038\/s41588-025-02289-w","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"14 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of the article initially published, Weiran Feng and Erik Ladewig were not listed as equal contributors and the sentence \u201cMatthew Lange, Nazifa Salsabeela and Huiyong Zhao are co-second authors\u201d was missing from the Author contributions. These omissions have now been corrected in the HTML and PDF versions of the article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.L.S. served on the Board of Directors of Novartis (2013\u20132025), is a co-founder of ORIC Pharmaceuticals and is co-inventor of enzalutamide and apalutamide. He is a science advisor to Beigene, Blueprint, CellCarta, Column Group, Foghorn, Housey Pharma, Nextech and PMV. Y.C. received research funding from Foghorn therapeutics, consulted for Fog Pharma and Belharra Therapeutics and has stock ownership of ORIC Pharmaceuticals. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}